In recent years, antibiotic resistance has increased dramatically, negatively impacting public health. Treatment approaches must be much more specific. Measures that limit antibiotic use in all human and veterinary applications are necessary to limit the development of new resistant species.
The discovery that the nervous system drives the progression and malignancy of several types of cancer has opened the way to a revolutionary branch of medicine called “Cancer Neuroscience”. How could this change therapy in the future?
The eye has long been considered by cultural tradition as the “soul mirror” because it reflects the body's deepest signals to the brain. Recent scientific research seems to confirm that the eyes can serve as a mirror for neurodegenerative diseases' early prediction.
On January 6, 2023, the Food and Drug American Agency (FDA) approved LEQEMBI for the treatment of Alzheimer’s disease. It belongs to the monoclonal antibody family and binds ß-amyloid fibres by disaggregating them.
Recent studies suggest a new revolutionary approach in detecting primitive stages of Alzheimer's disease through the identification of specific biomarkers many years before clinical signs are evident. Let's take a closer look.
Sodium oligomannate, a natural product derived from brown seaweed, is the first new compound approved for the treatment of Alzheimer's disease since 2003. Can a simple sugar be a new cure for patients? This article will give you some hints.